Kamada (KMDA) Net Cash Flow (2012 - 2026)
Kamada (KMDA) posted quarterly Net Cash Flow of -$42.3 million for Q1 2026, down 1768.71% year-on-year from $2.5 million in Q1 2025, and down 1272.34% on a QoQ basis from $3.6 million in Q4 2025.
Kamada (KMDA) Net Cash Flow (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Net Cash Flow for 15 consecutive years, with -$42.3 million the latest figure, recorded in Q1 2026.
- Quarterly Net Cash Flow fell 1768.71% year-over-year to -$42.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.8 million (down 252.33% YoY) and the FY2025 annual result came in at -$2.7 million, down 111.74% from the prior year.
- Net Cash Flow fell to -$42.3 million in Q1 2026 per KMDA's latest filing, from $3.6 million in the prior quarter.
- Over the last five years, Net Cash Flow for KMDA reached as high as $30.5 million in Q3 2023 and fell as low as -$42.3 million in Q1 2026.
- A 5-year average of $762796.0 and a median of $2.6 million in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 1887639.94% — and 2024, when it plunged 108339.56%.
- Year by year, Net Cash Flow stood at -$3.8 million in 2022, then soared by 166.54% to $2.6 million in 2023, then jumped by 164.71% to $6.8 million in 2024, then plunged by 46.62% to $3.6 million in 2025, then plunged by 1272.34% to -$42.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$42.3 million, $3.6 million, and $6.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | -42.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.35 Mn |
| Mar 31, 2026 | -42.35 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Sep 30, 2025 | 6.07 Mn |
| Sep 30, 2025 | 6.07 Mn |
| Jun 30, 2025 | -10.11 Mn |
| Jun 30, 2025 | -10.11 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Sep 30, 2024 | 15.30 Mn |
| Sep 30, 2024 | 15.30 Mn |
| Jun 30, 2024 | 8.28 Mn |
| Jun 30, 2024 | 8.28 Mn |
| Mar 31, 2024 | -7.40 Mn |
| Mar 31, 2024 | -7.40 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Dec 31, 2023 | 2.56 Mn |